Credits: Canva
France just raised its bird flu alert to "high" nationwide. Not just France, but Germany too raised alarm over bird flu, and have linked the risk to poultry farms as "high" as cases continue to rise across Europe.
The French agriculture ministry said that poultry farms are now required to keep their birds indoors and that authorities must aim "to strengthen surveillance and prevention measures" against the virus.
Reuters reported that "This decree was issued following evidence of infection among migratory wild birds in Europe, including France, and the confirmation of several outbreaks in poultry farms. So far, two bird flu outbreaks have been detected on poultry farms and three backyard flocks, the ministry said in the decree. A first case had ben detected in mid-October at a pheasant and partridge breeding farm in northern farm."
In Germany too, authorities have raised the risk level after several people came into contact with infected birds and other animals. This has raised the risk of the virus, and the fact that it could mutate and spread much more easily among people. This has also caused a concern among global health experts.
Other European countries which have also taken steps to address bird flu include the Dutch agriculture ministry that detected an outbreak on poultry farm, and lead to the culling 71,000 birds and also ordered to keep birds indoors.
In recent years, tens of millions of birds have been culled in Europe to prevent the virus from spreading. “The risk to human health in the EU/EEA is currently considered very low,” the European Centre for Disease Prevention and Control (ECDC) said in a press release.
Avian influenza, or bird flu, is a virus that affects birds, especially chickens, ducks, and wild waterfowl. This can spread fast through bird droppings, feathers, and contaminated surfaces. Since it spreads fast, so it can easily sneak into poultry farms, where thousands of birds live close together, and could give the virus the perfect chance to multiply and mutate.
While humans can get bird flu, the cases are rare. However, when it happens, it usually happens to those who work at poultry farms, or live near to them. Those who handle birds on a day to day basis, like market sellers, or vets are also at a higher risk.
However, one of the bird flu strains, the H5N1 is very dangerous and it can cause serious illness in humans if it jumps species. A few signs and symptoms which resemble those of regular flu initially, high fever, cough, sore throat, can sometimes turn extremely severe, leading to pneumonia or breathing problems, which can also be fatal. However, human-to-human spread is extremely uncommon, and health experts say there’s no need for panic.
Credits: Canva
While the term coronavirus is no longer part of our daily conversations, the investigation into how the UK handled the pandemic is still ongoing. The respiratory illness that first appeared in Wuhan, China, at the end of 2019 led the UK into two years of unprecedented lockdowns beginning in March 2020. By the end of 2023, there had been more than 235,000 COVID-related deaths in the UK, with countless others left grieving, dealing with long-term health effects, or facing financial difficulties.
The COVID inquiry was created to examine the decisions made during the crisis and assess how they affected everyday life across the country. Below, we explore what exactly the Covid inquiry is and why Boris Johnson is currently appearing before it.
Boris Johnson launched the Covid inquiry in June 2022, over a year after promising that the government’s pandemic response would be “put under the microscope,” according to the BBC. The announcement followed pressure from the Covid-19 Bereaved Families for Justice campaign, which had considered pursuing a judicial review over what it called government “delays.”
Johnson stated that the inquiry would review decisions made not only by the UK government but also by the administrations in Scotland, Wales, and Northern Ireland. The first public hearings were held in London in June 2023, with subsequent sessions in Edinburgh, Cardiff, and Belfast.
Public inquiries are set up and funded by the government but are led by an independent chair. They have the authority to require witnesses to provide evidence. They do not determine guilt or innocence, but instead publish conclusions and recommendations, which the government is not required to implement.
The inquiry is chaired by Baroness Hallett, a former judge and crossbench peer who previously oversaw the inquests into the 7 July London bombings. She has emphasised that the inquiry will place loss and suffering at its centre and assured that it would remain “firmly independent.”
The inquiry is divided into multiple modules. The first, which examined resilience and preparedness, has concluded, but investigations continue in several other areas:
There is no fixed timetable for when the inquiry will conclude.
The report on the first module was released in July 2024. It spans 83,000 words and draws from 103,000 submitted documents and 213 witness statements from 68 individuals. The report concluded that UK citizens were “failed” by the state, particularly due to shortcomings in planning, processes, and civil contingency structures within the UK government and devolved administrations.
It noted that the government had prepared for the “wrong pandemic,” focusing on influenza rather than coronaviruses, and suggested that some of the financial and human costs might have been avoided had the focus been different.
When former Prime Minister Boris Johnson gave evidence in late 2023, he expressed regret for the “pain, loss, and suffering” caused by the pandemic, though his remarks were interrupted by protesters holding signs that read: “The dead can’t hear your apologies.” Johnson acknowledged personal responsibility for decisions made and admitted that the government “may have made mistakes,” while emphasising that it had done its “level best” to respond to the virus.
He was questioned about meeting notes from 19 March 2020 in which he had reportedly asked why the government was “destroying everything for people who will die soon anyway,” referring to “bed blockers.” Johnson explained that the messages were not intended for public release but reflected the “cruelty of the choice” he faced and the “difficult balancing act” required during the pandemic.
He also admitted that the severity of the virus should have been recognised before March 2020, apologised for previously dismissing long COVID as “b*******,” and described media coverage of ‘partygate’ as “dramatic.”
On Tuesday, former Prime Minister Boris Johnson denied that his government had failed to adequately prepare for the “horror” of school closures during the COVID-19 crisis but apologised for mistakes made. This marked his second appearance before the inquiry he had agreed to establish after pressure from bereaved families. Two years ago, he defended himself against claims that his failure to heed scientific advice contributed to unnecessary deaths.
During this recent session, Johnson conceded that the UK government “probably did go too far” with some Covid-19 restrictions and admitted that children bore a “huge, huge price” during the pandemic. He told the inquiry that while ministers and officials were focused on tackling an “appalling public health crisis” in early 2020, the measures taken were, in hindsight, “far too elaborate.”
Credits: Canva
A UK-based doctor has urged people to speak with their GP about a “rare” and “fairly new” condition that, he says, can trigger almost any symptom, particularly in cases where the cause of an illness remains unclear.
Dr Asif Ahmed, a private GP and medical content creator known online as dra_says, explained that this condition is often difficult to diagnose and may be affecting far more people than currently recognised.
In one of his recent TikTok videos, Dr Ahmed said, “If you’ve got symptoms that no doctor seems able to explain, this new condition is something you should know about.”
According to a report by the Daily Record, Dr Ahmed believes many patients may have been misdiagnosed with other conditions instead of what is known as Mast Cell Activation Syndrome (MCAS), a disorder he describes as relatively new and still not widely understood.
Mast Cell Activation Syndrome (MCAS) is a health condition in which mast cells—immune cells that normally help protect the body—release chemicals inappropriately, leading to repeated bouts of symptoms that can affect different organs.
People with MCAS may experience flushing, hives, stomach pain, diarrhoea, breathing trouble, or headaches. These episodes can be brought on by a wide range of triggers, including stress, certain foods, or medications. Although research is still ongoing, experts believe MCAS is linked to an overactive or overly sensitive immune response involving mast cells.
Dr Asif Ahmed explained that mast cells exist throughout the body and are designed to support immune defence. He said that the feeling is somewhat similar to having an allergic reaction, but for those with MCAS, the reaction is stronger and usually affects more than one system in the body.
He told his audience: “These cells are always on the lookout for allergens, and when they detect one, they release histamine, which causes all those unpleasant symptoms. In MCAS, though, they’re triggered by things that shouldn’t normally set them off—like certain foods, temperature changes, or even stress.”
Warning Signs Of MCAS To Watch For:
According to him, standard test results often come back normal or borderline, which adds to the challenge of identifying it. Although there are specialist tests available, he noted that “these are not yet widely accessible through the NHS.”
Currently, there is no specific cure or single form of treatment for MCAS. Managing the condition largely depends on identifying and avoiding personal triggers, which is why keeping a diary can be helpful. The Cleveland Clinic also notes that certain medications may ease symptoms, particularly H1 and H2 receptor blockers, more commonly known as antihistamines.
Credits: Canva
Ibuprofen is a familiar name in most homes, a reliable fix for headaches, cramps, or joint aches. But new research hints that this everyday medicine could be doing far more than easing pain. Scientists now believe it might have properties that help guard against cancer. As studies continue to explore how inflammation contributes to tumour growth, ibuprofen’s potential role in this connection is drawing attention raising a compelling question: could something so ordinary actually offer protection against cancer? Let’s find out.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that helps relieve pain, lower fever, and control inflammation. It’s sold both over the counter and on prescription, under brand names like Advil and Motrin. This class of drugs, NSAIDs, has long been studied for its potential cancer-fighting effects. As early as 1983, researchers found that sulindac, an older NSAID similar to ibuprofen, was linked to a reduced risk of colon cancer in certain people. Since then, scientists have been examining whether these medicines might also help prevent or slow other cancers.
A 2025 study suggested that ibuprofen could lower the risk of endometrial cancer, the most common form of womb cancer. This cancer begins in the uterine lining (endometrium) and mainly affects postmenopausal women. Being overweight or obese is one of the most significant preventable risk factors, as excess fat raises oestrogen levels, a hormone that can encourage cancer growth.
Other risk factors include aging, diabetes, hormone replacement therapy (especially oestrogen-only HRT), and polycystic ovary syndrome (PCOS). Starting menstruation early, going through menopause late, or not having children can also raise risk. Common symptoms include abnormal vaginal bleeding, pelvic discomfort, and pain during sex.
The Prostate, Lung, Colorectal, and Ovarian (PLCO) study analysed data from more than 42,000 women aged 55–74 over 12 years. Those who took at least 30 ibuprofen tablets a month showed a 25% lower risk of developing endometrial cancer compared to those taking fewer than four tablets. The protective effect was especially noticeable among women with heart disease. Interestingly, aspirin, another NSAID, did not show the same link in this or other studies, though it may help stop bowel cancer from returning.
Other NSAIDs, including naproxen, have been researched for their potential to prevent colon, bladder, and breast cancers. Their success appears to depend on factors like cancer type, genetics, and existing health conditions.
Ibuprofen also seems to affect genes linked to cancer growth, such as HIF-1α, NFκB, and STAT3. These genes help tumour cells survive in low-oxygen conditions and resist treatment. By reducing the activity of these genes, ibuprofen may make cancer cells less resilient.
However, not all studies agree. Some reviews show that NSAIDs, especially aspirin, might lower the risk of several cancers, while long-term use of others could raise the risk of kidney cancer.
These mixed results highlight how complex the relationship between inflammation, immunity, and cancer truly is. Experts caution against taking ibuprofen regularly for prevention, as high doses or long-term use can lead to serious side effects like stomach ulcers, intestinal bleeding, and kidney problems.
Are There Any Side Effects of Taking Ibuprofen?
Ibuprofen is usually safe for short-term use, but it can cause several side effects, from mild digestive upset to more serious problems involving the heart, kidneys, or stomach, particularly with long-term or frequent use.
The thought that a simple painkiller could play a part in preventing cancer is both intriguing and hopeful. If future research confirms these findings, ibuprofen could one day be part of broader prevention strategies for people at higher risk. For now, though, the most reliable way to lower cancer risk remains unchanged: eat a balanced diet, stay active, and always seek medical advice before turning a common tablet into a long-term habit.
© 2024 Bennett, Coleman & Company Limited